Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7412636 | 1.00 | ALDH1A1 (0.46) | ALDH1A1KDM4ESMN1; SMN2HRH3CYP3A4 | |
| SCHEMBL7415772 | 0.96 | HRH3 (0.43) | ALDH1A1KDM4ESMN1; SMN2HRH3MCHR1 | |
| SCHEMBL7415767 | 0.96 | HRH3 (0.43) | ALDH1A1KDM4ESMN1; SMN2HRH3MCHR1 | |
| SCHEMBL7414755 | 0.96 | KDM4E (0.46) | ALDH1A1KDM4ESMN1; SMN2HRH3CYP3A4 | |
| SCHEMBL7414444 | 0.96 | KDM4E (0.46) | ALDH1A1KDM4ESMN1; SMN2HRH3CYP3A4 | |
| SCHEMBL7414441 | 0.96 | KDM4E (0.46) | ALDH1A1KDM4ESMN1; SMN2HRH3CYP3A4 | |
| SCHEMBL7406854 | 0.92 | HRH3 (0.44) | ALDH1A1KDM4ESMN1; SMN2HRH3MCHR1 | |
| SCHEMBL7408764 | 0.92 | HRH3 (0.44) | ALDH1A1KDM4ESMN1; SMN2HRH3MCHR1 | |
| SCHEMBL7412149 | 0.92 | HRH3 (0.44) | ALDH1A1KDM4ESMN1; SMN2HRH3MCHR1 | |
| SCHEMBL7415368 | 0.84 | KDM4E (0.43) | ALDH1A1KDM4EHRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0734379-B1 | 2-ARYLALKENYL-AZACYCLOALKANE DERIVATIVES AS SIGMA RECEPTOR LIGANDS, PREPARATION METHOD THEREFOR AND THERAPEUTICAL USE THEREOF | PARKE DAVIS (FR) | 2001-03-07 | — | — | EP | disclosed |
| EP-0995436-A2 | Ligands for sigma receptors and their therapeutical applications | PARKE-DAVIS (FR) | 2000-04-26 | — | — | EP | disclosed |
| US-6013656-A | PSYCHOLOGICAL DISORDERS; GASTROINTESTINAL DISORDERS; NERVOUSSYSTEM DISORDERS | WARNER-LAMBERT COMPANY (US) | 2000-01-11 | — | — | US | disclosed |
| US-5849760-A | 2-(arylalkenyl)azacycloalkane derivatives as ligands for sigma receptors | INSTITUT DE RECHERCHE JOUVEINAL (FR) | 1998-12-15 | — | — | US | disclosed |
| EP-0734379-A1 | NOVEL 2-ARYLALKENYL-AZACYCLOALKANE DERIVATIVES AS SIGMA RECEPTOR LIGANDS, PREPARATION METHOD THEREFOR AND THERAPEUTICAL USE THEREOF | INSTITUT DE RECHERCHE JOUVEINAL (I.R.J) (FR) | 1996-10-02 | — | — | EP | disclosed |
| WO-1995015948-A1 | NOVEL 2-ARYLALKENYL-AZACYCLOALKANE DERIVATIVES AS SIGMA RECEPTOR LIGANDS, PREPARATION METHOD THEREFOR AND THERAPEUTICAL USE THEREOF | INSTITUT DE RECHERCHE JOUVEINAL (FR) | 1995-06-15 | — | — | WO | disclosed |